Legg Mason Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Legg Mason Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-11,500	Closed	-$578K	–	116
2016 Q2	$578K	Sell	11,500 -300	-3%	-$16K	0.62%	87
2016 Q1	$632K	Hold	11,800	–	–	0.65%	83
2015 Q4	$775K	Sell	11,800 -600	-5%	-$37.1K	0.81%	61
2015 Q3	$701K	Sell	12,400 -600	-5%	-$38.9K	0.71%	70
2015 Q2	$769K	Sell	13,000 -1,000	-7%	-$61.7K	0.7%	71
2015 Q1	$873K	Buy	+14,000	New	+$814K	0.71%	62

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Legg Mason Asset Management's TEVA Position: Q3 2016 in Review

Legg Mason Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2016, closing a stake of 11,500 shares — an estimated $578K sold.

Legg Mason Asset Management first reported a position in TEVA in Q1 2015 and held it in 6 quarters. The position peaked at $873K in Q1 2015. 798 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Legg Mason Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2016 after selling out during the quarter.
Legg Mason Asset Management sold 11,500 Teva Pharmaceutical Industries Limited shares in Q3 2016, an estimated $578K.
Legg Mason Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2015 and held it in 6 quarters.
Legg Mason Asset Management's Teva Pharmaceutical Industries Limited position peaked at $873K in Q1 2015.
798 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2016.

Based on Legg Mason Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.